Valproate-associated coagulopathies in children during short-term treatment

Journal of Child Neurology

Volumn 24, Issue 12, 2009, Pages 1493-1498

  KÖse, Gg̈lsen ^a   Arhan, Ebru ^a   Unal, Bahadir ^a   Ozaydin, Eda ^a   Guven, Alev ^a   Sayli, Tulin R ^a  

^a Diskapi Children's Hospital   (Turkey)

Author keywords

Coagulopathy; Factor VII; Short term treatment; Thrombosis; Valproate

Indexed keywords

VALPROIC ACID;

ABSENCE; ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLEEDING; BLOOD CLOTTING DISORDER; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; FEMALE; FIBRINOGEN BLOOD LEVEL; GENERALIZED EPILEPSY; HUMAN; MALE; MYOCLONUS EPILEPSY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; SHORT COURSE THERAPY; SIDE EFFECT; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOEMBOLISM; TONIC CLONIC SEIZURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ANTICONVULSANTS; BIOLOGICAL MARKERS; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; BLOOD PROTEIN DISORDERS; CHILD; CHILD, PRESCHOOL; DOWN-REGULATION; DRUG ADMINISTRATION SCHEDULE; EPILEPSY; FACTOR VII; FACTOR VIII; FEMALE; FIBRINOGEN; HOMOCYSTEINE; HUMANS; LIPOPROTEIN(A); MALE; PLATELET COUNT; PROSPECTIVE STUDIES; PROTEIN C; VALPROIC ACID;

EID: 75149188314     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073808331084     Document Type: Article

References (31)

1. Serdaro?lu G., TG̈tG̈ncG̈o?lu S., Kavakl± K., TekgG̈l H. Coagulation abnormalities and acquired von Willebrands disease type 1 in children receiving valproic acid. J Child Neurol. 2002 ; 17: 41-43.
2. Banerjea MC, Diener W., Kutschke G., Schneble HJ, Korinthenberg R., Sutor AH Pro-and anticoagulatory factors under sodium valproate therapy in children. Neuropediatrics. 2002 ; 33: 215-220.
3. Zeller JA, Schlesinger S., Runge U., Kessler C. Influence of valproate monotherapy on platelet activation and hematologic values. Epilepsia. 1999 ; 40: 186-189.
4. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia. 1981 ; 22: 489-501.
5. Eastham RD, Jancar J. Letter: sodium valproate and platelet counts. Br Med J. 1980 ; 280: 186.
6. von Czettritz G., Weinmann HM GerinnungsstÖrung unter valproinsCurrency signure. In: KrCurrency signmer G, Laub M, eds. ValproinsCurrency signure. Heidelberg: Springer-Verlag; 1992: 210-216.
7. Hauser E., Seidl R., Freilinger M., et al. Hematologic manifestations and impaired liver synthetic function during valproate monotherapy. Brain Dev. 1996 ; 18: 105-109.
8. Covanis A., Gupta AK, Jeavons PM Sodium valproate: monotherapy and polytherapy. Epilepsia. 1982 ; 23: 693-720.
9. Barr RD, Copeland SA, Stockwell ML, Morris N., Kelton JC Valproic acid and immune thrombocytopenia. Arch Dis Child. 1982 ; 57: 681-684.
10. Neophytides AN, Nutt JG, Lodish JR Thrombocytopenia associated with sodium valproate treatment. Ann Neurol. 1979 ; 5: 389-390. 11.
11. Smith FR, Boots M. Sodium valproate and bone marrow suppression. Ann Neurol. 1980 ; 8: 197-199.
12. Delgado MR, Riela AR, Mills J., Browne R., Roach ES Thrombocytopenia secondary to high valproate levels in children with epilepsy. J Child Neurol. 1994 ; 9: 311-314.
13. Ganick DJ, Sunder T., Finley JL Severe hematologic toxicity of valproic acid. A report of four patients. Am J Pediatr Hematol Oncol. 1990 ; 12: 80-85.
14. Gidal B., Spencer N., Maly M., et al. Valproate-mediated disturbances of hemostasis: relationship to dose and plasma concentration. Neurology. 1994 ; 44: 1418-1422.
15. Ko CH, Kong CK, Tse TWT Valproic acid and thrombocytopenia: cross-sectional study. Hong Kong Med J. 2001 ; 7: 15-21.
16. Gerstner T., Teich M., Bell N., et al. Valproate-associated coagulopathies are frequent and variable in children. Epilepsia. 2006 ; 47: 1136-1143.
17. Loiseau P. Sodium valproate, platelet dysfunction and bleeding. Epilepsia. 1981 ; 22: 141-146. (Pubitemid 11156668)
18. Acharya S., Bussel JB Hematologic toxicity of sodium valproate. J Pediatr Hematol Oncol. 2000 ; 22: 62-65.
19. von Voss H., Schulte-Berbuhl R., Gobel U. Side effects of sodium valproate (sodium di-N-propylacetate) on malonyldialdehyde production and other platelet function tests. Minerva Pediatr. 1978 ; 30: 1397-1404.
20. Sandler RM, Emberson C., Roberts GE, Voak D., Darnborough J., Heeley AF IgM platelet auto-antibody due to sodium valproate. BMJ. 1978 ; 2: 1683-1684.
21. Morris N., Barr RD, Pai KRM, Kelton JG Valproic acid and thrombocytopenia. Can Med Assoc J. 1981 ; 125: 63-64.
22. Koenig S., Gerstner T., Keller A., Teich M., Longin E., Dempfle CE High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study. Blood Coagul Fibrinolysis. 2008 ; 19: 375-382.
23. Wagner C., Dato F. Fibrinogen. In: Thomas L, ed. Labor und Diagnose. Frankfurt/main: TH-Books Verlaggesellschaft mbH ; 1998: 624-627.
24. Majer RV, Green PJ Neonatal afibrinogenaemia due to sodium valproate. Lancet. 1987 ; 2: 740-741.
25. Anai T., Hirota Y., Oga M., Yoshimatsu J., Miyakawa I. PIVKA-II (protein induced by vitamin K absence-II) status in newborns exposed to anticonvulsant drugs in utero. Nippon Sanka Fujinka Gakkai Zasshi. 1991 ; 43: 347-350.
26. Cordes I., Buchmann S., Scheffner D. Vitamin K deficiency with erythromycin. Observation of a boy treated with valproate. Monatsschr Kinderheilkd. 1990 ; 138: 85-87.
27. Tam DA Jr, Myer EC Vitamin K-dependent coagulopathy in a child receiving anticonvulsant therapy. J Child Neurol. 1996 ; 11: 244-246.
28. Unalp A., Dirik E., Kurul S. Factor VII deficiency associated with valproate treatment. Pediatr Int. 2008 ; 50: 403-405.
29. Chambers HG, Weinstein CH, Mubarak SJ, Wenger DR, Silva PD The effect of valproic acid on blood loss in patients with cerebral palsy. J Pediatr Orthop. 1999 ; 19: 792-795.
30. Bechtold H., Andrassy K. Vitamin K und medikamenteninduzierte Hypoprothrombinamie. Hamostaseologie. 1988 ; 8: 8-17.
31. Gruppo R., Grauw A., Fogelson H., Glauser T., Balasa V., Gartside P. Protein C deficiency related to valproic acid therapy: A possible association with childhood stroke. J Pediatr. 2000 ; 137: 714-718.